pharmaceutical industry

The articles in this collection provide valuable coverage and insights into the practices of drug manufacturers, the driving forces behind the costs we face today, and what, if anything, can be done to satiate the hunger of big pharma. Media literacy questions and terms will engage readers beyond the text and aid them in considering the many facets of this complicated issue.

From its beginning as a small start-up in the late 19th century, Jonson & Johnson has grown into one of the world's largest corporations. Its long history, global reach, and corporate influence have allowed the company to become a household name throughout North America and in various parts of the world.

"When the application for a new sedative called Kevadon--commonly known as thalidomide--landed on Frances Kelsey's desk at the FDA in 1960, it seemed destined to sail through the review process. The drug, billed as entirely risk-free, was already being sold in forty-six countries. But when Kelsey learned that the drug caused terrible birth defects, she and a team of dedicated doctors, parents, and journalists fought Merrell, the drug's American manufacturer, and Chemie-Gruenenthal, the German company founded by former Nazis that first synthesized the drug, to recall the product. It marked a rare victory in America's perennial battle between capitalism and consumer protection"--Provided by publisher.

Presents a portrait of three generations of the Sackler family, who built their fortune on the sale of Valium and later sponsored the creation and marketing of one of the most commonly prescribed and addictive painkillers of the opioid crisis.

"[Presents] the story of a pharmacy in Kermit, West Virginia, that distributed nearly nine million opioid pain pills in two years to a town with 382 people -- and of one woman desperate for justice after losing her brother to an overdose"--Jacket flap.

Contains over 750 alphabetically arranged entries that provide information on terminology, concepts, and individuals associated with cancer and cancer research.

"... introduces ... scientists, in-corruptible regulators,and ... whistle-blowers facing off against [the pharmaceutical industry] company executives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are partof the industry's DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. ... also uncovers thereal story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis"--Jacket flap.

A collection of essays with differing viewpoints on the pharmaceutical industry.

To many Americans, the term big pharma evokes thoughts of greedy organizations that put profits ahead of people's health. It's difficult to put a price tag on drugs that improve or save lives. It's even harder to stomach the thought of being unable to afford medicines when we may need them most. With the price of pills reaching an all-time high, we are looking for justifications and turning to our government for solutions. The articles in this collection provide valuable coverage and insights into the practices of drug manufacturers, the driving forces behind the costs we face today, and what, if anything, can be done to satiate the hunger of big pharma. Media literacy questions and terms will engage readers beyond the text and aid them in considering the many facets of this complicated issue.

Explores the issues surrounding big pharma and drug pricing by placing opinions from a wide range of sources in a pro/con format. Features articles that express various perspectives on this topic.